Protagonist Therapeutics Inc (PTGX)
Operating Income
$158.77M
Quarterly · Period ending: · USD
PTGX Operating Income
Latest reported$158.77Mperiod ending
Latest reported$158.77Mperiod ending
PTGX Quarterly Operating Income (-$2.69M → $158.77M)
Quarterly operating income
High-resolution chart · PNG
PTGX operating income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| 158,766,000 | |
| -3,648,000 | |
| -50,355,000 | |
| -46,421,000 | |
| -42,041,000 | |
| -19,310,000 | |
| 126,780,000 | |
| -41,453,000 | |
| -38,793,000 | |
| 206,309,000 | |
| 23,049,000 | |
| -38,326,000 | |
| -42,354,000 | |
| -36,021,000 | |
| -36,516,000 | |
| -32,303,000 | |
| -41,443,000 | |
| -21,111,000 | |
| -37,916,000 | |
| -33,926,000 | |
| -30,882,000 | |
| -24,021,000 | |
| -18,830,000 | |
| -7,772,000 | |
| -18,217,000 | |
| -19,697,000 | |
| -17,299,000 | |
| -17,167,000 | |
| -31,407,000 | |
| -14,648,000 | |
| -15,412,000 | |
| -9,389,000 | |
| -9,239,000 | |
| -8,229,000 | |
| -3,513,000 | |
| -4,980,000 | |
| -15,131,000 | |
| -14,273,000 | |
| -11,397,000 | |
| -7,138,000 | |
| -7,091,000 | |
| -7,040,000 | |
| -5,001,000 | |
| -4,021,000 | |
| -3,083,000 | |
| -2,689,000 |